comparemela.com

Latest Breaking News On - Carl byrnes - Page 2 : comparemela.com

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Q3 2023 Earnings Call Transcript November 9, 2023 Oncternal Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.17 EPS, expectations were $-0.15. Operator: Greetings and welcome to Oncternal Therapeutics third-quarter 2023 financial results conference call. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to […]

London
City-of
United-kingdom
Salim-yazji
James-breitmeyer
Carl-byrnes
Matthew-smith
Evan-yu
Fred-hutch
Richard-vincent
Professor-johann-de-bono

Northland Upgrades Esperion Therapeutics (ESPR) to Market Perform. 'Potential Resolution of DSE Litigation as Catalysts'

Northland Upgrades Esperion Therapeutics (ESPR) to Market Perform. 'Potential Resolution of DSE Litigation as Catalysts'
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Carl-byrnes
Northland-capital-markets
Esperion-therapeutics
Market-perform

BioLife Solutions, Inc. (NASDAQ:BLFS) Q1 2023 Earnings Call Transcript

Operator: Hello. My name is Mallory, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2023 BioLife Solutions, Inc. Earnings Conference Call.

Paul-knight
Michael-rice
Yuan-zhi
Troy-wichterman
Carl-byrnes
Jacob-johnson
Mike-rice
Biolife-solutions
Biolife-solutions-inc
Nasdaq
Scisafe-storage-services

vimarsana © 2020. All Rights Reserved.